1. Home
  2. Analysis
  3. Tazicef
  4. Heparin-sodium

Tazicef and Heparin sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 3 people who take Tazicef and Heparin sodium. Common interactions include azotaemia among males.

The phase IV clinical study analyzes what interactions people who take Tazicef and Heparin sodium have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 29, 2023

3 people who take Tazicef and Heparin sodium together, and have interactions are studied.

What is Tazicef?

Tazicef has active ingredients of ceftazidime. Currently, eHealthMe is studying from 45 Tazicef users.

What is Heparin sodium?

Heparin sodium has active ingredients of heparin sodium. It is used in deep venous thrombosis. Currently, eHealthMe is studying from 19,769 Heparin sodium users.

Number of Tazicef and Heparin sodium reports submitted per year:

Tazicef and Heparin sodium drug interactions.

Common Tazicef and Heparin Sodium drug interactions by gender *:

female:

n/a

male:

  1. Azotaemia
  2. Anaemia
  3. Cerebrovascular accident
  4. Chemical burns of eye
  5. Coma hepatic
  6. Death
  7. Depression
  8. Device failure
  9. Dysthymic disorder
  10. Eye infection staphylococcal

Common Tazicef and Heparin Sodium drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Azotaemia
  2. Blood pressure decreased
  3. Catheter site haemorrhage
  4. Device failure
  5. Hepatic necrosis
  6. Multi-organ failure
  7. Pneumothorax
  8. Renal failure
  9. Septic shock

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Chemical burns of eye
  2. Eye infection staphylococcal
  3. Eye injury
  4. Eye irritation
  5. Ulcerative keratitis
  6. Visual impairment

60+:

  1. Anaemia
  2. Aphasia
  3. Death
  4. Depression
  5. Dysthymic disorder
  6. Failure to thrive
  7. Fatty liver alcoholic
  8. Gastrooesophageal reflux disease
  9. Gout
  10. Hypotension

* Approximation only. Some reports may have incomplete information.

Do you take Tazicef and Heparin sodium?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Browse interactions between Tazicef and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Heparin sodium drug interactions:

Browse interactions between Heparin sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime and heparin sodium (the active ingredients of Tazicef and Heparin sodium, respectively), and Tazicef and Heparin sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Tazicef and Heparin sodium.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.